Patient Anxiety About Prostate Cancer Independently Predicts Early Initiation of Androgen Deprivation Therapy for Biochemical Cancer Recurrence in Older Men: A Prospective Cohort Study

PURPOSE: Androgen deprivation therapy (ADT) is first-line therapy for patients with prostate cancer (PCA) who experience biochemical recurrence (BCR). However, the optimal timing of ADT initiation is uncertain, and earlier ADT initiation can cause toxicities that lower quality of life (QOL). We test...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dale, William, Hemmerich, Joshua, Bylow, Kathryn, Mohile, Supriya, Mullaney, Mary, Stadler, Walter M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2009
Témata:
Original Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738613/
https://ncbi.nlm.nih.gov/pubmed/19255325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.5850
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky